Related Experiment Video
Updated: Jul 7, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The invention of the programmable implantable medication system
1Appl. Phys. Lab., Johns Hopkins Univ., Baltimore, MD.
Summary
This study details the creation of a programmable implantable medication system, covering challenges from concept to prototype. It also explores funding, development, marketing, and bringing medical inventions to the public.
Area of Science:
- Biomedical Engineering
- Medical Device Development
- Drug Delivery Systems
Background:
- The development of novel medical devices is crucial for advancing patient care.
- Programmable implantable medication systems offer potential for improved therapeutic outcomes.
- Translating innovative medical ideas into functional prototypes presents significant hurdles.
Purpose of the Study:
- To outline the conceptualization and development process of a programmable implantable medication system.
- To identify and discuss the challenges encountered during the creation of the first prototype.
- To share insights into the funding, development, and marketing of medical inventions.
Main Methods:
- Retrospective analysis of the invention process.
- Case study of a programmable implantable medication system.
- Qualitative description of development and commercialization challenges.
Main Results:
- The genesis of the programmable implantable medication system idea.
- Identification of key problems faced during prototype development.
- Discussion of funding, development, and marketing strategies.
- Observations on the pathway of medical inventions to public use.
Conclusions:
- The journey from concept to a marketable medical device is complex and multifaceted.
- Overcoming technical and logistical challenges is essential for medical invention success.
- Understanding the development lifecycle aids in bringing new medical technologies to patients.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...